EyeWorld Weekly, February 12, 2021
➤ NDA filed for topical glaucoma and ocular hypertension ophthalmic solution ➤ Nepafenac vs. placebo, results from Phase 2 study ➤ Enrollment completed for photobiomodulation treatment trial ➤ ASCRS activity updates
Comments Off on EyeWorld Weekly, February 12, 2021
February 12, 2021
